Skip to main content
Premium Trial:

Request an Annual Quote

Do Proteins Point the Way to Cancer?

Premium

At the TedMed 2010 meeting last October, researcher Danny Hillis made a case for proteomics being "the next frontier of cancer research," says blogger GrrlScientist at The Guardian. Hillis says that genomics shows us the components of the body that could lead to cancer, while proteomics explains how those components come together to actually produce the disease.

But GrrlScientist says she's "skeptical" about the methodology and that it needs much more work before it can be applied to patients, adding, "I am confused as to what we can learn about a solid tumor by analyzing proteins in one drop of blood."

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.